Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
15,0000
Clinical Trial Start Date
December 21, 2018
0Primary Completion Date
2050
0Study Completion Date
2050
0Clinical Trial Study Type
Observational0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Other0
Participating Facility
Official Name
A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions0
Last Updated
October 24, 2023
0Study summary
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
